Banner

Regenerative Medicine For Cartilage Global Market Report 2023 – By Treatment Modality (Cell Based, Non Cell Based), By Treatment Type (Palliative, Intrinsic Repair Stimulus, Other Treatment Types), By Site (Knee Cartilage Repair, Ribs, Other Sites), By Application (Hyaline Cartilage Repair and Regeneration, Elastic Cartilage Repair and Regeneration, Fibrous Cartilage Repair and Regeneration), By End Use (Ambulatory Surgical Centers, Hospitals and Clinics, Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : h1213 | Delivery Time: 2-3 business days | Format :


Regenerative medicine for cartilage refer to a medication used during surgery to repair damaged cartilage in the knees using body-produced cells that can create cartilage. A biopsy is required to collect chondrocytes (cells that produce cartilage), which are then multiplied in a lab before being implanted into the injured area during surgery.

 

The main types of regenerative medicine for cartilage are cell-based and non-cell-based. The type of treatment includes palliative and intrinsic repair stimulus among others that are used by ambulatory surgical centers, hospitals and clinics, and surgical centers. The regenerative medicine for cartilage is used for hyaline cartilage repair and regeneration, elastic cartilage repair and regeneration, and fibrous cartilage repair and regeneration.

The regenerative medicine for cartilage market research report is one of a series of new reports from The Business Research Company that provides regenerative medicine for cartilage market statistics, including regenerative medicine for cartilage industry global market size, regional shares, competitors with a regenerative medicine for cartilage market share, detailed regenerative medicine for cartilage market segments, market trends and opportunities, and any further data you may need to thrive in the regenerative medicine for cartilage industry. This regenerative medicine for cartilage market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

 

The global regenerative medicine for cartilage market size grew from $5.28 billion in 2022 to $5.82 billion in 2023 at a compound annual growth rate (CAGR) of 10.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The regenerative medicine for cartilage market size is expected to grow to $7.72 billion in 2027 at a CAGR of 7.3%.

 

The growing incidence of osteoarthritis across the globe will drive the market for regenerative medicine for cartilage. Osteoarthritis is a degenerative joint disorder that mostly attacks the articular cartilage. According to the Arthritis Foundation, degenerative joint disease disorders such as osteoarthritis will impact at least 130 million individuals around the globe by 2050. Some of the most commonly used treatments for osteoarthritis are autologous chondrocyte implantation and scaffold implants. Thus, the increasing incidence of osteoarthritis is expected to drive the demand for the market for regenerative medicine for cartilage.

 

The high cost of regenerative medicine therapies is one of the major factors limiting the growth of the market for regenerative medicine for cartilage. The average cost for knee replacement is around $4,500 to $8,400, while the average cost of cartilage repair procedures is around $18,000, depending on the country where the procedure is being performed. Such high prices discourage individuals to resort to cartilage repair therapies and, in turn, result in a lower preference for these procedures.

 

Tissue engineering and stem cell therapy are emerging trends in regenerative medicine for the cartilage market. The growth of tissue engineering technology has given hope for the regeneration of cartilage. Stem cell therapy is gaining attention with its advantages over traditional orthopaedic treatments. Stem cell therapy helps to reduce knee pain and improves knee cartilage regeneration and repair. For instance, growth factors in the form of platelet-rich plasma (PRP) therapy are injected to promote tissue regeneration effectively. Companies operating in the market are continuously focusing on introducing new technologies to survive in the regenerative medicine for cartilage market.

In September 2020, Smith & Nephew plc, a UK-based multinational medical equipment manufacturing company, acquired the orthopaedics business of Integra LifeSciences Holdings Corporation for an amount of $240 million. The acquisition is expected to stimulate growth in Smith & Nephew’s extremities business by adding a targeted sales channel, a portfolio of compatible upper and lower extremities, shoulder replacements, and an intriguing new product pipeline. Integra LifeSciences Holdings Corporation is a US based medical device manufacturing company specializing in solutions in extremities orthopedics, neurosurgery, and regenerative technologies, all geared toward reducing clinician uncertainty.

 

Major players in the regenerative medicine for cartilage market are B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew PLC, Arthrex Inc., CONMED Corporation, Collagen Solutions PLC, BioTissue Technologies, CellGenix, Osiris Therapeutics Inc., and DePuy Synthes.

 

Europe was the largest region in regenerative medicine for cartilage in 2022. The regions covered in the regenerative medicine for cartilage market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

 

The countries covered in the regenerative medicine for cartilage market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The regenerative medicine for cartilage market consists of sales of cartilage regeneration, platelet-rich plasma (PRP), and prolotherapy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global regenerative medicine for cartilage market is segmented -

1) By Treatment Modality: Cell-Based, Non-Cell-Based

2) By Treatment Type: Palliative, Intrinsic Repair Stimulus, Other Treatment Types

3) By Site: Knee Cartilage Repair, Ribs, Other Sites

4) By Application: Hyaline Cartilage Repair and Regeneration, Elastic Cartilage Repair and Regeneration, Fibrous Cartilage Repair and Regeneration

5) By End-Use: Ambulatory Surgical Centers, Hospitals & Clinics, Surgical Centers, Other End-Users

    Table Of Contents

    1. Executive Summary

    2. Regenerative Medicine For Cartilage Market Characteristics

    3. Regenerative Medicine For Cartilage Market Trends And Strategies

    4. Regenerative Medicine For Cartilage Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Regenerative Medicine For Cartilage Market

    4.2. Ukraine-Russia War Impact On Regenerative Medicine For Cartilage Market

    4.3. Impact Of High Inflation On Regenerative Medicine For Cartilage Market

    5. Regenerative Medicine For Cartilage Market Size And Growth

    5.1. Global Regenerative Medicine For Cartilage Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Regenerative Medicine For Cartilage Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Regenerative Medicine For Cartilage Market Segmentation

    6.1. Global Regenerative Medicine For Cartilage Market, Segmentation By Treatment Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Cell-Based

    Non-Cell-Based

    6.2. Global Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Palliative

    Intrinsic Repair Stimulus

    Other Treatment Types

    6.3. Global Regenerative Medicine For Cartilage Market, Segmentation By Site, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Knee Cartilage Repair

    Ribs

    Other Sites

    6.4. Global Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hyaline Cartilage Repair and Regeneration

    Elastic Cartilage Repair and Regeneration

    Fibrous Cartilage Repair and Regeneration

    6.5. Global Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Ambulatory Surgical Centers

    Hospitals & Clinics

    Surgical Centers

    Other End-Users

    7. Regenerative Medicine For Cartilage Market Regional And Country Analysis

    7.1. Global Regenerative Medicine For Cartilage Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Regenerative Medicine For Cartilage Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Regenerative Medicine For Cartilage Market

    8.1. Asia-Pacific Regenerative Medicine For Cartilage Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Regenerative Medicine For Cartilage Market

    9.1. China Regenerative Medicine For Cartilage Market Overview

    9.2. China Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Regenerative Medicine For Cartilage Market

    10.1. India Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Regenerative Medicine For Cartilage Market

    11.1. Japan Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Regenerative Medicine For Cartilage Market

    12.1. Australia Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Regenerative Medicine For Cartilage Market

    13.1. Indonesia Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Regenerative Medicine For Cartilage Market

    14.1. South Korea Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Regenerative Medicine For Cartilage Market

    15.1. Western Europe Regenerative Medicine For Cartilage Market Overview

    15.2. Western Europe Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Regenerative Medicine For Cartilage Market

    16.1. UK Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Regenerative Medicine For Cartilage Market

    17.1. Germany Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Regenerative Medicine For Cartilage Market

    18.4. France Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Regenerative Medicine For Cartilage Market

    19.1. Eastern Europe Regenerative Medicine For Cartilage Market Overview

    19.2. Eastern Europe Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Regenerative Medicine For Cartilage Market

    20.1. Russia Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Regenerative Medicine For Cartilage Market

    21.1. North America Regenerative Medicine For Cartilage Market Overview

    21.2. North America Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Regenerative Medicine For Cartilage Market

    22.1. USA Regenerative Medicine For Cartilage Market Overview

    22.2. USA Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Regenerative Medicine For Cartilage Market

    23.1. South America Regenerative Medicine For Cartilage Market Overview

    23.2. South America Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Regenerative Medicine For Cartilage Market

    24.1. Brazil Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Regenerative Medicine For Cartilage Market

    25.1. Middle East Regenerative Medicine For Cartilage Market Overview

    25.2. Middle East Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Regenerative Medicine For Cartilage Market

    26.1. Africa Regenerative Medicine For Cartilage Market Overview

    26.2. Africa Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Regenerative Medicine For Cartilage Market Competitive Landscape And Company Profiles

    27.1. Regenerative Medicine For Cartilage Market Competitive Landscape

    27.2. Regenerative Medicine For Cartilage Market Company Profiles

    27.2.1. B. Braun Melsungen AG

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Zimmer Biomet Holdings Inc.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Vericel Corporation

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Stryker Corporation

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Smith & Nephew plc

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Regenerative Medicine For Cartilage Market

    29. Regenerative Medicine For Cartilage Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Regenerative Medicine For Cartilage Market, Segmentation By Treatment Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Regenerative Medicine For Cartilage Market, Segmentation By Site, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Global Regenerative Medicine For Cartilage Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Global Regenerative Medicine For Cartilage Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: Asia-Pacific, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: China, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: China, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: India, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: India, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Japan, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Japan, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Australia, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Australia, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Indonesia, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: Indonesia, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: South Korea, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: South Korea, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Western Europe, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: Western Europe, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: UK, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: UK, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: Germany, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: Germany, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: France, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: France, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Eastern Europe, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Eastern Europe, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: Russia, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: Russia, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: North America, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: North America, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: USA, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: USA, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: South America, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: South America, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Brazil, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Brazil, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Middle East, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Middle East, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Africa, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47: Africa, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 48: B. Braun Melsungen AG Financial Performance
  • Table 49: Zimmer Biomet Holdings Inc., Financial Performance
  • Table 50: Vericel Corporation Financial Performance
  • Table 51: Stryker Corporation Financial Performance
  • Table 52: Smith & Nephew plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Regenerative Medicine For Cartilage Market, Segmentation By Treatment Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Regenerative Medicine For Cartilage Market, Segmentation By Site, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Global Regenerative Medicine For Cartilage Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Global Regenerative Medicine For Cartilage Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: Asia-Pacific, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: China, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: China, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: India, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: India, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Japan, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Japan, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Australia, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Australia, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Indonesia, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: Indonesia, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: South Korea, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: South Korea, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Western Europe, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: Western Europe, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: UK, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: UK, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: Germany, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: Germany, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: France, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: France, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Eastern Europe, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Eastern Europe, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: Russia, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: Russia, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: North America, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: North America, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: USA, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: USA, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: South America, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: South America, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Brazil, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Brazil, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Middle East, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Middle East, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Africa, Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47: Africa, Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 48: B. Braun Melsungen AG Financial Performance
  • Figure 49: Zimmer Biomet Holdings Inc., Financial Performance
  • Figure 50: Vericel Corporation Financial Performance
  • Figure 51: Stryker Corporation Financial Performance
  • Figure 52: Smith & Nephew plc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report